LONDON: BioPharma Credit PLC, a leading debt investment trust listed on the London Stock Exchange (LSE: BPCR), has declared a substantial financial agreement through its wholly owned subsidiary and in conjunction with BioPharma Credit Investments V (Master) LP. The partnership has secured a senior loan agreement with Novocure Luxembourg S.a.r.l., a subsidiary of the NASDAQ-listed…